Optum Launches Specialty Fusion to Simplify Specialty Care and Lower Costs

Rhea-AI Summary

Optum has launched Optum® Specialty Fusion™, a unique solution aimed at managing the rising costs of specialty medicines, projected to reach $505 billion by 2023. This innovative platform offers health care payers real-time insights into effective specialty treatments, achieving up to 17% savings on total medical and pharmacy expenses. Specialty Fusion simplifies the prior authorization process and enhances patient care by expediting treatment approvals by an expected 50%, ultimately reducing administrative burdens for healthcare providers.

Positive

• Launch of Optum Specialty Fusion provides up to 17% savings in specialty drug costs.
• Expected 50% faster access to therapy for patients.
• Real-time insights allow providers to compare treatment options and lower costs.

Negative

• None.

First-to-market solution helps health care payers manage the increasing cost of specialty medicines, delivering up to 17% savings across medical and pharmacy spend

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- Optum today announced the launch of Optum® Specialty Fusion™, a first-of-its-kind specialty medication management solution, to simplify care for patients with complex conditions and lower the cost of expensive specialty drugs.

With specialty drug costs projected to reach $505 billion by 2023, health plans and care providers are seeking ways to ensure people get the treatments they need more affordably. Using Optum’s data and clinical expertise, Specialty Fusion provides health care payers and care providers real-time insight into the most effective specialty treatment at the lowest cost to the patient. Results include a simpler experience for providers and faster treatment approvals for patients, while delivering 17% total cost savings in medical and pharmacy spend.¹

“The average specialty patient sees more than five care providers per year, while taking more than 10 drugs on average. They often have to wait for multiple treatment regimens to be approved, and need better support navigating their treatment plan and health benefits,” said Kerri Tanner, senior vice president, Optum Rx. “We developed a new comprehensive, benefit-agnostic solution that supports streamlined treatment decision-making for care providers, helping patients get on their therapies faster, while driving down high costs.”

In line with Optum’s commitment to develop solutions that provide more transparency and better connect the pharmacy and medical benefits across health care, Specialty Fusion was designed to streamline and simplify the medication management process. Using Specialty Fusion, care providers can initiate the approval process for specialty drugs requiring prior authorization using a single portal. Treatment options are then compared against dozens of clinically appropriate, lower-cost options across benefits in seconds. Specialty Fusion eliminates the need for a cross-benefit prior authorization process – a burden for providers – and secures treatment approval in real time. This reduces administrative hassle and results in an expected 50% faster access to therapy for patients, while lowering costs.

For example, when a provider prescribes an immunosuppressive drug on the medical benefit, treatment may cost $1,200. Using Specialty Fusion, a provider can see coverage recommendations and select a therapeutically equivalent treatment for $700 less, on average. Informed by Optum data and insights, Specialty Fusion provides savings options such as preferred products, dosage management policies, best sites of care and additional cost-control levers such as available discounts and pharmacy networks.²

"Managing specialty drugs at the earliest possible moment is critical to improving care, clinical outcomes and the patient experience," said Sarah Dye, senior vice president, Optum Health. "Optum Specialty Fusion uniquely partners with the provider to change the status quo of prior authorization, reduce their administrative pain and ultimately help them provide better care for their patients.”

Optum Specialty Fusion is now available to all large health plans. Additional information is available here.

About Optum

Optum is a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 180,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group (NYSE: UNH). For more information, visit www.optum.com.

Sources

1. Optum internal analysis. 2021. Actual savings will vary depending on client programs in place.
2. Optum internal analysis. 2021. Actual savings will vary depending on client programs in place. 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20220217005265/en/

Optum

Jennifer Statham

(952) 205-7747

jennifer.statham@optum.com

Source: Optum

FAQ

What is Optum Specialty Fusion and how does it impact specialty medicine costs for UNH?

Optum Specialty Fusion is a new medication management solution designed to manage the rising costs of specialty medicines, offering up to 17% savings for health care payers.

How much can health plans save using Optum Specialty Fusion?

Health plans can achieve up to 17% savings across medical and pharmacy spend using Optum Specialty Fusion.

When was Optum Specialty Fusion launched?

Optum Specialty Fusion was announced on February 17, 2022.

What is the expected impact of Specialty Fusion on treatment approval times?

Specialty Fusion is expected to reduce treatment approval times by 50%, allowing quicker access to necessary therapies for patients.

What company is behind the development of Specialty Fusion?

Optum, a part of UnitedHealth Group (NYSE: UNH), developed the Specialty Fusion solution.